Mental Health
Jolly Good Inc. Establishes North American Subsidiary: Joint Development of Medical VR for "Apple Vision Pro" with U.S. Experts
~ First Phase: Joint Development of Chronic Pain VR with U.S. Chronic Pain Experts TOKYO, Nov. 1, 2023 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as Jolly Good), which develops and provides medical VR, announces that it has established a North Ame...
Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS"
TOKYO, Sept. 27, 2023 /PRNewswire/ -- Emotional Link LLC
Growing Awareness of Brain Health for Senior Dogs as Cascade Animal Sciences Launches "Neuro-Pro"
ATLANTA, June 20, 2023 /PRNewswire/ -- Cascade Animal Sciences, an animal health start-up based inthe United States and Australia, is proud to announce the launch of its first dietary supplement product "Neuro-Pro". Neuro-Pro is designed for middle-to-senior-aged dogs and dogs that require neuro...
MINDLAX REVOLUTIONIZES SLEEP SOLUTIONS WITH VIBROACOUSTIC SLEEPING MAT
The MindLax Sleeping Mat uses tactile-aural mechanisms that trigger the body's natural processes to induce relaxation and aid better sleep COLORADO SPRINGS, Colo., Feb. 20, 2023 /PRNewswire/ -- MindLax, the leading innovator in natural sleep and relaxation products and maker of the MindLax Sleep...
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1] which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2...
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health
- World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - TOKYO, Dec. 6, 2022 /PRNewswire/ -- The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on bio...
Ybrain Receives Translational Research Award 2022 Neuroergonomics Conference & NYC Neuromodulation Conference
NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Ybrain recently received the
Translational Research Award at this year'sNeuroergonomics Conference and NYC
Neuromodulation Conference
Announcing the Release of The Disruptors, the First Comprehensive Documentary Film on ADHD Award-Winning, Star-Studded Documentary Available in Australia on Apple TV/iTunes, Google Play, and YouTube
GREENWICH, Conn., Aug. 17, 2022 /PRNewswire/ -- Following its successful US debut, THE DISRUPTORS – the first definitive, comprehensive documentary film on ADHD, one of the most commonly diagnosed, and widely misunderstood neurological conditions in the world today – is now available inAustralia ...
Taiwanese Startup E-Kids Helps the Elderly with Butler Services Built on Psychotherapy Principles
* Butler-type service provides companionship and services such as tech assistance * Elderly are served by youths trained to communicate using psychotherapy principles * Psychotherapy matters a lot to many people all over the world, E-Kids to help deliver TAIPEI, July 28, 2022 /PRNewswire/ -...
THE WORLD'S FIRST ACADEMIC PAPER ON THE POTENTIAL USE OF VIRTUAL REALITY IN MODULATING PSYCHEDELIC-ASSISTED PSYCHOTHERAPY PUBLISHED BY THE CO-FOUNDERS OF ENOSIS THERAPEUTICS
The Peer-Reviewed Article Published In Volume 13 March 2022 Issue Of Frontiers In Psychology Journal Is A Landmark Examination Of Virtual Reality Therapy Combined With Psychedelic Therapy. MELBOURNE, Australia, March 10, 2022 /PRNewswire/ -- The world's first scientific paper offering a careful...
Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease
MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders
ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development progr...
Paw for Good launches crowdfunding program to create a mutually beneficial ecosystem by transforming stray dogs into instructors for people with special needs
TAOYUAN, Taiwan, Sept. 9, 2021 /PRNewswire/ -- In September 2021, the Paw for
Good team of Chung Yuan University Industry Accelerator and Incubator Center
(IAIC) launched thePaw For Good Interactive Education Program
Week's Top Stories
Most Reposted
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 313 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 301 media titles]
2026-08-06 15:10GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
[Picked up by 296 media titles]
2026-08-12 16:02MetaOptics Ltd achieves 79% of FY2025 full-year revenue in 1H 2026, on track to fulfil purchase orders of key metalens production equipment in 2H 2026
[Picked up by 293 media titles]
2026-08-11 19:03Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements
[Picked up by 292 media titles]
2026-08-10 19:12